Pacific Biosciences of California, Inc. Diluted Shares Outstanding (Weighted Average)
Pacific Biosciences of California, Inc. (PACB) reported Diluted Shares Outstanding (Weighted Average) of 310.65 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-06
- Pacific Biosciences of California, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 310.65M shares, a 3.50% increase year-over-year.
- Pacific Biosciences of California, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 305.82M shares, a 3.02% increase year-over-year.
- Pacific Biosciences of California, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 301.93M shares, a 10.82% decline year-over-year.
- Pacific Biosciences of California, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 300.84M shares, a 10.23% increase year-over-year.
- Pacific Biosciences of California, Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 299.96M shares, a 4.02% increase from fiscal 2024.
- Pacific Biosciences of California, Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 288.37M shares, a 13.70% increase from fiscal 2023.
- Pacific Biosciences of California, Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 253.63M shares, a 12.95% increase from fiscal 2022.
- Pacific Biosciences of California, Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 224.55M shares, a 10.00% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 310.65M shares 10-Q · filed 2026-08-06 | 308.25M shares 10-Q · filed 2026-08-06 | 306.13M shares derived: average of 3 quarters · filed 2026-08-06 | 304.81M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 305.82M shares 10-Q · filed 2026-05-08 | 303.87M shares derived: average of 2 quarters · filed 2026-05-08 | 302.86M shares derived: average of 3 quarters · filed 2026-05-08 | 302.19M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 301.93M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | 301.39M shares derived: average of 2 quarters · filed 2026-02-25 | 300.98M shares derived: average of 3 quarters · filed 2026-08-06 | 299.96M shares 10-K · filed 2026-02-25 |
| 2025-09-30 | 300.84M shares 10-Q · filed 2025-11-06 | 300.50M shares derived: average of 2 quarters · filed 2026-08-06 | 299.30M shares 10-Q · filed 2025-11-06 | 309.11M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 300.16M shares 10-Q · filed 2026-08-06 | 298.52M shares 10-Q · filed 2026-08-06 | 311.86M shares derived: average of 3 quarters · filed 2026-08-06 | 302.13M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 296.86M shares 10-Q · filed 2026-05-08 | 317.71M shares derived: average of 2 quarters · filed 2026-05-08 | 302.78M shares derived: average of 3 quarters · filed 2026-05-08 | 295.18M shares derived: average of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | 338.57M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | 305.74M shares derived: average of 2 quarters · filed 2026-02-25 | 294.62M shares derived: average of 3 quarters · filed 2026-02-25 | 288.37M shares 10-K · filed 2026-02-25 |
| 2024-09-30 | 272.92M shares 10-Q · filed 2025-11-06 | 272.65M shares derived: average of 2 quarters · filed 2025-11-06 | 271.63M shares 10-Q · filed 2025-11-06 | 270.54M shares derived: average of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | 272.38M shares 10-Q · filed 2025-08-07 | 270.98M shares 10-Q · filed 2025-08-07 | 269.74M shares derived: average of 3 quarters · filed 2026-02-25 | 266.06M shares derived: average of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | 269.58M shares 10-Q · filed 2025-05-12 | 268.42M shares derived: average of 2 quarters · filed 2026-02-25 | 263.95M shares derived: average of 3 quarters · filed 2026-02-25 | 260.48M shares derived: average of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | 267.27M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | 261.14M shares derived: average of 2 quarters · filed 2026-02-25 | 257.45M shares derived: average of 3 quarters · filed 2026-02-25 | 253.63M shares 10-K · filed 2026-02-25 |
| 2023-09-30 | 255.00M shares 10-Q · filed 2024-11-12 | 252.54M shares derived: average of 2 quarters · filed 2024-11-12 | 249.08M shares 10-Q · filed 2024-11-12 | 243.34M shares derived: average of 4 quarters · filed 2025-03-17 |
| 2023-06-30 | 250.07M shares 10-Q · filed 2024-08-09 | 246.07M shares 10-Q · filed 2024-08-09 | 239.45M shares derived: average of 3 quarters · filed 2025-03-17 | 235.87M shares derived: average of 4 quarters · filed 2025-03-17 |
| 2023-03-31 | 242.03M shares 10-Q · filed 2024-05-09 | 234.14M shares derived: average of 2 quarters · filed 2025-03-17 | 231.14M shares derived: average of 3 quarters · filed 2025-03-17 | 229.48M shares derived: average of 4 quarters · filed 2025-03-17 |
| 2022-12-31 | 226.26M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | 225.69M shares derived: average of 2 quarters · filed 2025-03-17 | 225.29M shares derived: average of 3 quarters · filed 2025-03-17 | 224.55M shares 10-K · filed 2025-03-17 |
| 2022-09-30 | 225.12M shares 10-Q · filed 2023-11-03 | 224.81M shares derived: average of 2 quarters · filed 2023-11-03 | 223.98M shares 10-Q · filed 2023-11-03 | 223.21M shares derived: average of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | 224.50M shares 10-Q · filed 2023-08-04 | 223.40M shares 10-Q · filed 2023-08-04 | 222.57M shares derived: average of 3 quarters · filed 2024-02-28 | 220.71M shares derived: average of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | 222.29M shares 10-Q · filed 2023-05-04 | 221.60M shares derived: average of 2 quarters · filed 2024-02-28 | 219.44M shares derived: average of 3 quarters · filed 2024-02-28 | 214.22M shares derived: average of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | 220.91M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | 218.02M shares derived: average of 2 quarters · filed 2024-02-28 | 211.53M shares derived: average of 3 quarters · filed 2024-02-28 | 204.14M shares 10-K · filed 2024-02-28 |
| 2021-09-30 | 215.13M shares 10-Q · filed 2022-11-08 | 206.85M shares derived: average of 2 quarters · filed 2022-11-08 | 198.54M shares 10-Q · filed 2022-11-08 | 208.44M shares derived: average of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | 198.57M shares 10-Q · filed 2022-08-08 | 196.69M shares 10-Q · filed 2022-08-08 | 206.22M shares derived: average of 3 quarters · filed 2023-02-28 | 196.38M shares derived: average of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | 194.79M shares 10-Q · filed 2022-05-06 | 210.04M shares derived: average of 2 quarters · filed 2023-02-28 | 195.65M shares derived: average of 3 quarters · filed 2023-02-28 | 185.28M shares derived: average of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | 225.29M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | 196.08M shares derived: average of 2 quarters · filed 2023-02-28 | 182.11M shares derived: average of 3 quarters · filed 2023-02-28 | 174.97M shares 10-K · filed 2023-02-28 |
| 2020-09-30 | 166.86M shares 10-Q · filed 2021-11-05 | 160.52M shares derived: average of 2 quarters · filed 2021-11-05 | 158.19M shares 10-Q · filed 2021-11-05 | |
| 2020-06-30 | 154.17M shares 10-Q · filed 2021-08-06 | 153.23M shares 10-Q · filed 2021-08-06 | ||
| 2020-03-31 | 155.85M shares 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | 152.53M shares 10-K · filed 2022-02-28 | |||
| 2019-03-31 | 151.27M shares 10-Q · filed 2020-05-08 | |||
| 2018-12-31 | 135.09M shares 10-K · filed 2021-02-26 | |||
| 2016-09-30 | 92.11M shares 10-Q · filed 2016-11-04 | 87.97M shares 10-Q · filed 2016-11-04 | ||
| 2015-12-31 | 78.33M shares 10-K · filed 2017-03-06 | 79.40M shares derived: average of 2 quarters · filed 2017-03-06 | 77.85M shares derived: average of 3 quarters · filed 2017-03-06 | 76.92M shares derived: average of 4 quarters · filed 2017-03-06 |
| 2015-09-30 | 80.48M shares 10-K · filed 2017-03-06 | 77.61M shares derived: average of 2 quarters · filed 2017-03-06 | 74.70M shares 10-Q · filed 2016-11-04 | |
| 2015-06-30 | 74.73M shares 10-K · filed 2017-03-06 | 74.44M shares derived: average of 2 quarters · filed 2017-03-06 | ||
| 2015-03-31 | 74.15M shares 10-K · filed 2017-03-06 | |||
| 2014-09-30 | 70.74M shares 10-Q · filed 2015-11-05 | 69.72M shares 10-Q · filed 2015-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |